Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy.

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

However, no studies have investigated influences on cessation among women using nicotine replacement therapy (NRT).

Who Took Part

The abstract describes 1,050 women taking part.

By PubMed's age tags, the people studied were young adults and adults, women only.

Data were collected at baseline, 1 month, and delivery from 1,050 pregnant women.

How the Study Was Run

The researchers set it up as a randomized study.

The women were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

Two multivariable logistic models for validated cessation at 1 month and delivery were created with a systematic strategy for selection of included factors.

What Was Measured

PubMed files the paper under topics including Cotinine, Logistic Models, Nicotine, Smoking, Smoking Cessation and Tobacco Use Cessation Devices.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 1,050 women.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2014 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.